March 29, 2006

Bayer announces the launch of a EUR 2 billion mandatory convertible bond

Subordinated mandatory convertible bond due in June 2009 / Conversion into shares of Bayer AG

Leverkusen, March 29, 2006 - Bayer Capital Corporation B.V., Mijdrecht offers
investors today a bond, mandatory convertible into shares of Bayer AG, with an issue
volume of EUR 2 billion. The bond will mandatorily convert into new shares, created
from the existing conditional capital of Bayer AG, at maturity in June 2009. The
mandatory convertible bond will be issued without pre-emptive rights for existing

The bond is subordinated and enjoys a subordinated guarantee from Bayer AG. The
bond offers investors an attractive annual coupon expected to be within a range of
6.25 to 6.75%, whereas the company participates in the upside from any future share
price appreciation up to the conversion premium level of 16 - 20%. The final coupon
and conversion premium will be determined during the course of today by way of an
accelerated bookbuilding. The issue volume of EUR 2 billion can be increased by up
to EUR 300 million if the overallotment option is exercised.

The net proceeds will be used among others as part of the financing of the intended
acquisition of Schering AG and is part of the previously announced equity capital
raising measures of up to EUR 4 billion. The bond will be sold in a private placement
to institutional investors only.

Based on the mandatory conversion into new shares of Bayer AG at maturity and the
subsequent strengthening of the equity capital, the company expects that the bond will
receive a high equity credit treatment from rating agencies.

Forward-looking statements<br/>
This announcement contains forward-looking statements based on current assumptions and forecasts made by Bayer
Group management. Various known and unknown risks, uncertainties and other factors could lead to material
differences between the actual future results, financial situation, development or performance of the company and the
estimates given here. These factors include those discussed in the annual and interim reports of Bayer AG to the
Frankfurt Stock Exchange and in our reports filed with the SEC. Bayer AG and Bayer Capital Corporation B.V. do
not assume any liability whatsoever to update these forward-looking statements or to conform them to future events
or developments.

This announcement is for general information only and does not form part of any offer to sell, or the solicitation of
any offer to buy, securities. The distribution of this announcement and the offer and sale of the securities described in
this announcement in certain jurisdictions may be restricted by law. Any persons reading this announcement should
inform themselves of and observe any such restrictions. This announcement may not be taken, distributed or
transmitted, directly or indirectly, in any form in or into Italy, the United States, Canada or Japan. This
announcement is not an offer of securities for sale in the United States. The offer and sale of the securities referred to
in this announcement has not been, nor will it be, registered under the United States Securities Act of 1933 and the
securities referred to in this announcement may not be offered or sold in the United States absent such registration or
an applicable exemption from registration. There will be no public offer of these securities in the United States
This communication is directed only at persons who (i) are outside Italy, the United Kingdom, the United States,
Canada or Japan or (ii) have professional experience in matters relating to investments or (iii) are persons falling
within Article 49 (2)(a) to (d) ("high net worth companies, unincorporated associations etc") of The Financial Services
and Markets Act 2000 (Financial Promotion) Order 2001 (all such persons together being referred to as "relevant
persons"). This communication must not be acted on or relied on by persons who are not relevant persons. Any
investment or investment activity to which this communication relates is available only to relevant persons and will be
engaged in only with relevant persons.

This announcement is not an offer of securities for sale in Germany and is not a listing prospectus according to the
German Securities Prospectus Act (Wertpapierprospektgesetz) as amended, the Commission Regulation (EC) No
809/2004 of 29 April 2004 as amended, or any other laws applicable in Germany governing the issue, offering and sale
of securities. Any investment decisions or advices for investment decisions should only be made or given based on a
prospectus which also includes a section on risk factors.



Current Event

November 3, 2020

Q3 2020 Quarterly Statement